Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: A case report and review of the literature

Steve Hu, Pranshu Bansal, David Lynch, Cristhiam Mauricio Rojas Hernandez, Zoneddy Dayao

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: A case report and review of the literature'. Together they form a unique fingerprint.

Medicine & Life Sciences